Biopharma
🇺🇸 FDA Page 6FDA news and analysis for pharmaceutical BD, investment, and market access · 9 articles on this page
Global biopharma insights for investors & BD. Track drug development, M&A, and market trends shaping the pharmaceutical landscape.
Showing 61–69 of 69 articles
M&A Trends: Mid-Size Pharma Companies on the Rise
NICE Approval for Imfinzi: Implications for Stomach Cancer Treatment
Pharma Partnering US: $77.3B Licensing Deals in Q1 2026
Fierce Biotech Week 2026: AI & Oncology Pipeline Recap
Biosimilars Market Analysis: US Landscape Post-Inflation Reduction Act 2026
FDA Breakthrough Therapy TargTex TX202: What You Need to Know
FDA Approves BriaCell's Bria-IMT: Novel CAR-T Therapy for Advanced Breast Cancer
CAR-T Cell Therapy Advancements and FDA Regulatory Pathways 2024
FDA Breakthrough Therapy Designations: Advancing Alzheimer's Drug Development